---
title: "Liminatus Pharma Soars 50% During Regular Trading to $0.17"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291556559.md"
description: "Liminatus Pharma jumped 50% in regular trading to $0.1726, after gaining 40.9% in premarket."
datetime: "2026-07-02T13:41:27.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291556559.md)
  - [en](https://longbridge.com/en/news/291556559.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291556559.md)
generator: "portal-rs"
---

# Liminatus Pharma Soars 50% During Regular Trading to $0.17

Liminatus Pharma(LIMN.US) 盘中涨超**50%**，现报**0.1726**美元，当日精确涨幅**50.35%**。

该股盘前交易中已上涨**40.9%**至**0.16**美元，盘中延续强势走势。根据早盘交易数据，Liminatus Pharma 为当日医疗保健板块表现突出的异动股之一。

### Related Stocks

- [LIMN.US](https://longbridge.com/en/quote/LIMN.US.md)

## Related News & Research

- [Liminatus Pharma sets 1-for-50 reverse stock split effective Aug. 20](https://longbridge.com/en/news/296264260.md)
- [Liminatus Pharma discloses Ewon Comfortech initial beneficial ownership of 5.5 million shares](https://longbridge.com/en/news/291844263.md)
- [Hanger Ventures invests in Prosthetic Fit 360 in private financing round](https://longbridge.com/en/news/296149025.md)
- [Liminatus Pharma annual meeting draws 48.31% of shares represented](https://longbridge.com/en/news/294876806.md)
- [Liminatus Pharma Q2 FY26 net loss widens to $1.41 million; operating loss widens 23% to $1.38 million](https://longbridge.com/en/news/295975537.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**